Primary Myelofibrosis

10 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Hematologic Diseases, Myeloproliferative Disorders

Treatments and conditions

Primary Myelofibrosis
Treatment and conditionWhere it standsTrials
Givinostat for primary myelofibrosisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Luspatercept for primary myelofibrosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Navitoclax for primary myelofibrosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Pelabresib for primary myelofibrosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Peripheral Blood Hematopoietic Cell Transplantation (HCT) + Total body irradiation (TBI) + Cyclophosphamide + Busulfan + FLUDARABINE + FILGRASTIM + Mycophenolate Mofetil Hydrochloride + Sirolimus for primary myelofibrosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ruxolitinib + NAVITOCLAX for primary myelofibrosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Selinexor for primary myelofibrosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tasquinimod for primary myelofibrosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
TASQUINIMOD + Ruxolitinib for primary myelofibrosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
ULIXERTINIB + Ruxolitinib for primary myelofibrosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.